| Primary information |
|---|
| sequence ID | Seq_7483 |
| Peptide sequence | SPMYSIITPNILRLESEETM |
| CancerPDF_ID | CancerPDF_ID226, |
| PMID | 19728888 |
| Protein Name | Complement C3 beta/f |
| UniprotKB Entry Name | CO3_HUMAN |
| Fluid | Serum |
| M/Z | 2324.1475 |
| Profiling Technique | MALDI-TOF |
| Peptide Identification technique | LC-MS/MS |
| Labelled/Label Free | Label Free |
| CancerPDF_ID | CancerPDF_ID226, |
| p-Value | less than 0.01 |
| Software | MASCOT(v 2.0.04 for Windows) |
| Length | 20 |
| Cancer Type | "Non-small cell lung cancer (NSCLC) patients, who were treated with first-line chemotherapy" |
| Database | SwissProt Database (release 54.7) |
| Modification | NA |
| Number of Patients | "27 patients, 13 normal individuals" |
| Regulation | Signature peptide that can Differentiate between NSCLC patients and healthy volunteers |
| Validation | Independent validation |
| Sensitivity | 1 |
| Specificity | 0.96 |
| Accuracy | 0.98 |
| Peptide Atlas | NA |
| IEDB | NA |